Estados financieros detallados de Esperion Therapeutics, Inc. (ESPR): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Esperion Therapeutics, Inc. registró ingresos de $403.1M en el último ejercicio fiscal, con un CAGR de 5 años del 12.1%.
Márgenes de los últimos 12 meses: margen bruto 65.0%, margen operativo 18.1%, margen neto -1.8%.
Al precio actual de $3.18, ESPR presenta beneficios negativos (P/E no significativo) y un ROE del 1.99%. La capitalización bursátil es de $661M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | $184.5M | $148.4M | $227.5M | $78.4M | $75.5M | $116.3M | $332.3M | $403.1M |
| Coste de Ventas | $252000 | $258000 | $265000 | 0 | $2.4M | $14.2M | $27.0M | $43.3M | $68.6M | $129.2M |
| Beneficio Bruto | -$252000 | -$258000 | $184.2M | $148.4M | $225.2M | $64.2M | $48.5M | $73.1M | $263.7M | $273.9M |
| I+D | $57.9M | $147.6M | $171.5M | $175.6M | $146.9M | $106.0M | $118.9M | $86.1M | $46.2M | $47.9M |
| Generales y Administrativos | $18.3M | $21.4M | $33.1M | $65.9M | $199.6M | $185.0M | $109.1M | $142.5M | $163.1M | $165.8M |
| Gastos Operativos | $76.2M | $169.0M | $204.6M | $241.5M | $346.6M | $291.0M | $228.0M | $228.6M | $209.3M | $213.6M |
| Beneficio Operativo | -$76.2M | -$169.0M | -$204.6M | -$93.1M | -$121.4M | -$226.7M | -$179.5M | -$155.6M | $54.4M | $60.3M |
| EBITDA | -$74.3M | -$166.5M | -$204.3M | -$88.7M | -$120.3M | -$222.1M | -$176.3M | -$150.1M | $7.6M | $63.9M |
| Gastos por Intereses | $376000 | $198000 | $100000 | $8.1M | $22.7M | $46.4M | $56.8M | $59.0M | $59.3M | $84.6M |
| Beneficio Antes de Impuestos | -$75.0M | -$167.0M | -$201.8M | -$97.2M | -$143.6M | -$269.1M | -$233.7M | -$209.2M | -$51.7M | -$20.8M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.8M |
| Beneficio Neto | -$75.0M | -$167.0M | -$201.8M | -$97.2M | -$143.6M | -$269.1M | -$233.7M | -$209.2M | -$51.7M | -$22.7M |
| BPA | $-3.33 | $-6.98 | $-7.54 | $-4.02 | $-6.05 | $-11.03 | $-4.33 | $-2.03 | $-0.28 | $-0.11 |
| BPA Diluido | $-3.33 | $-6.98 | $-7.54 | $-4.02 | $-6.05 | $-11.03 | $-4.33 | $-2.03 | $-0.28 | $-0.11 |
| Acciones en Circulación (Diluidas) | $22.5M | $23.9M | $26.8M | $27.1M | $27.5M | $28.9M | $66.4M | $103.1M | $187.2M | $207.9M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 |
|---|
| Ingresos | $82.4M | $87.3M | $168.4M | $80.1M |
| Beneficio Bruto | $53.8M | $31.9M | $140.6M | $45.5M |
| Beneficio Operativo | $7.1M | -$10.0M | $85.2M | -$6.6M |
| EBITDA | $7.8M | -$9.3M | $86.3M | -$45.0M |
| Beneficio Neto | -$12.7M | -$31.3M | $61.8M | -$25.2M |
| BPA | $-0.02 | $-0.16 | $0.26 | $-0.10 |
| BPA Diluido | $-0.02 | $-0.16 | $0.22 | $-0.10 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $38.2M | $34.5M | $37.0M | $166.1M | $305.0M | $208.9M | $124.8M | $82.2M | $144.8M | $167.9M |
| Inversiones a Corto | 0 | 0 | 0 | $34.7M | 0 | $50.4M | $42.1M | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | $12.4M | $22.9M | $33.7M | $48.5M | $80.1M | $140.2M |
| Inventario | 0 | 0 | 0 | 0 | $16.1M | $34.4M | $35.2M | $65.6M | $94.5M | $105.1M |
| Activos Corrientes | $213.6M | $203.9M | $142.6M | $211.7M | $345.9M | $329.0M | $246.7M | $201.1M | $338.0M | $462.6M |
| Inmovilizado Material | $674000 | $435000 | $520000 | $2.7M | $7.3M | $2.6M | $1.2M | $4.7M | $5.8M | $3.3M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $56000 | $56000 | $56000 | $56000 | $56000 | $56000 | $56000 | $56000 | $56000 | $56000 |
| Activos Totales | $245.2M | $277.8M | $143.5M | $214.4M | $353.3M | $381.6M | $247.9M | $205.8M | $343.8M | $465.9M |
| Cuentas por Pagar | $4.6M | $20.4M | $44.9M | $28.9M | $52.0M | $17.6M | $23.0M | $31.7M | $51.6M | $65.1M |
| Deuda a Corto | $1.7M | $1.0M | 0 | 0 | 0 | $12.7M | $25.1M | $34.8M | $102.2M | $89.7M |
| Pasivos Corrientes | $15.6M | $33.1M | $64.3M | $66.1M | $94.1M | $73.4M | $92.3M | $156.2M | $246.2M | $300.8M |
| Deuda a Largo | $1.0M | 0 | 0 | 0 | $179.4M | $258.3M | $259.9M | $501.5M | $483.7M | $457.6M |
| Pasivos Totales | $16.6M | $33.1M | $64.3M | $194.5M | $449.4M | $578.5M | $571.7M | $660.8M | $732.5M | $767.9M |
| Reservas | -$229.2M | -$396.3M | -$598.1M | -$695.3M | -$838.8M | -$1.11B | -$1.34B | -$1.55B | -$1.60B | -$1.62B |
| Patrimonio Neto | $228.6M | $244.7M | -$598.1M | $19.9M | -$96.1M | -$196.9M | -$323.8M | -$455.0M | -$388.7M | -$302.0M |
| Deuda Total | $2.7M | $1.0M | 0 | $1.6M | $185.4M | $260.2M | $260.9M | $540.9M | $591.2M | $548.0M |
| Deuda Neta | -$35.4M | -$33.4M | -$37.0M | -$199.2M | -$119.6M | $863000 | $94.1M | $458.7M | $446.5M | $380.1M |
| Capital Circulante | $198.0M | $170.8M | $78.3M | $145.6M | $251.8M | $255.6M | $154.4M | $44.8M | $91.8M | $161.8M |
Balance (Trimestral)
| Año | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 |
|---|
| Caja y Equivalentes | $86.1M | $92.4M | $167.9M | $156.2M |
| Activos Totales | $347.1M | $364.0M | $465.9M | $462.5M |
| Pasivos Totales | $780.6M | $815.4M | $767.9M | $770.5M |
| Patrimonio Neto | -$433.5M | -$451.4M | -$302.0M | -$307.9M |
| Deuda Total | $598.2M | $601.0M | $548.0M | $543.8M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$75.0M | -$167.0M | -$201.8M | -$97.2M | -$143.6M | -$269.1M | -$233.7M | -$209.2M | -$51.7M | -$22.7M |
| Amortizaciones | $252000 | $258000 | $265000 | $319000 | $547000 | $612000 | $500000 | $164000 | $63000 | $105000 |
| Compensación en Acciones | $16.0M | $18.6M | $24.0M | $25.9M | $28.4M | $24.3M | $15.2M | $12.0M | $12.0M | $9.9M |
| Cambio en Capital Circulante | $10.0M | $16.5M | $29.2M | -$7.3M | -$4.3M | -$52.5M | -$3.4M | $13.7M | -$60.5M | -$14.6M |
| Flujo de Caja Operativo | -$47.7M | -$131.3M | -$148.6M | -$70.3M | -$85.2M | -$263.8M | -$174.8M | -$135.5M | -$23.7M | -$13.1M |
| Inversiones (CapEx) | -$94000 | -$19000 | -$151000 | -$953000 | -$13.4M | 0 | 0 | 0 | -$317000 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | $12.5M | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | -$55.0M | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$47.8M | -$131.3M | -$148.8M | -$71.3M | -$98.5M | -$263.8M | -$174.8M | -$135.5M | -$24.0M | -$13.1M |
Flujo de Caja (Trimestral)
| Año | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 |
|---|
| Flujo de Caja Operativo | -$31.4M | -$4.3M | $45.2M | -$27.7M |
| Inversiones (CapEx) | 0 | 0 | $189000 | -$189000 |
| Flujo de Caja Libre | -$31.4M | -$4.3M | $45.4M | -$27.9M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $2.7M | $2.3M | $2.4M | $2.5M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | -19.6% | +53.4% | -65.5% | -3.8% | +54.1% | +185.7% | +21.3% |
| Crecimiento Beneficio Neto (anual) | | -122.7% | -20.9% | +51.9% | -47.7% | -87.5% | +13.2% | +10.4% | +75.3% | +56.2% |
| Crecimiento BPA (anual) | | -109.6% | -8.0% | +46.7% | -50.5% | -82.3% | +60.7% | +53.1% | +86.2% | +60.7% |
| Cambio en Acciones (anual) | | +6.2% | +11.8% | +1.3% | +1.4% | +5.2% | +129.8% | +55.3% | +81.5% | +11.0% |
| Crecimiento FCF (anual) | | -174.6% | -13.3% | +52.1% | -38.2% | -167.7% | +33.7% | +22.5% | +82.3% | +45.4% |
| Margen Bruto | | | 99.9% | 100.0% | 98.9% | 81.9% | 64.3% | 62.8% | 79.4% | 67.9% |
| Margen Operativo | | | -110.9% | -62.8% | -53.3% | -289.0% | -237.8% | -133.7% | 16.4% | 15.0% |
| Margen EBITDA | | | -110.8% | -59.8% | -52.9% | -283.2% | -233.7% | -129.0% | 2.3% | 15.8% |
| Margen Neto | | | -109.4% | -65.5% | -63.1% | -343.0% | -309.6% | -179.9% | -15.6% | -5.6% |
| Margen FCF | | | -80.7% | -48.1% | -43.3% | -336.3% | -231.6% | -116.5% | -7.2% | -3.2% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -8.8% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-2.12 | $-5.49 | $-5.56 | $-2.63 | $-3.59 | $-9.13 | $-2.63 | $-1.31 | $-0.13 | $-0.06 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $22.5M | $23.9M | $26.8M | $27.1M | $27.5M | $28.9M | $66.4M | $103.1M | $187.2M | $207.9M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 1.99% |
| Rentabilidad sobre capital invertido | 30.98% |
| Rentabilidad sobre activos | -1.60% |
| Margen bruto | 65.00% |
| Margen operativo | 18.12% |
| Margen neto | -1.77% |
Salud financiera
| Deuda / Patrimonio | -1.77 |
| Ratio corriente | 1.53 |
| Piotroski F-Score | 5 |
| Altman Z-Score | -2.57 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -3.76 | -9.43 | -6.10 | -14.83 | -4.30 | -0.45 | -1.44 | -1.47 | -7.86 | -33.64 |
| P/VC | 1.23 | 6.44 | -2.06 | 80.97 | -7.43 | -0.73 | -1.28 | -0.68 | -1.06 | -2.55 |
| P/V | 0.00 | 0.00 | 6.67 | 10.89 | 3.14 | 1.84 | 5.48 | 2.65 | 1.24 | 1.91 |
| Margen Bruto | 0.0% | 0.0% | 99.9% | 100.0% | 98.9% | 81.9% | 64.3% | 62.8% | 79.4% | 67.9% |
| Margen Operativo | 0.0% | 0.0% | -110.9% | -62.8% | -53.3% | -289.0% | -237.8% | -133.7% | 16.4% | 15.0% |
| Margen Neto | 0.0% | 0.0% | -109.4% | -65.5% | -63.1% | -343.0% | -309.6% | -179.9% | -15.6% | -5.6% |